Policies, adaptations, and ongoing challenges to naloxone, buprenorphine and nonprescription syringe access across four-states: Findings from an environmental scan and key informant interviews
Floyd A, Silcox J, Strickler G, Nong T, Blough M, Bolivar D, Rabin M, Bratberg J, Irwin A, Hartung D, Hansen R, Bohler R, Green T. Policies, adaptations, and ongoing challenges to naloxone, buprenorphine and nonprescription syringe access across four-states: Findings from an environmental scan and key informant interviews. Drug And Alcohol Dependence Reports 2024, 11: 100243. PMID: 38948428, PMCID: PMC11214408, DOI: 10.1016/j.dadr.2024.100243.Peer-Reviewed Original ResearchNonprescription syringesImplementation of evidence-based interventionsEnvironmental scanEvidence-based interventionsCost of medicationsSemi-structured interviewsHarm reduction organizationsPatients' stigmaNaloxone standing orderRural settingsStanding ordersActive partnershipPharmacy policiesPharmacy chainInformant interviewsStructural barriersMedicaid coverageSyringe accessDispensing buprenorphineInstitutionalized interventionsPharmacyMortality increaseKey informantsRandomized trialsIntervention